UNSPSC 85501260: Occlusion of left internal carotid artery with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left internal carotid artery with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03LL3DZ

UNSPSC 85501260 Occlusion of left internal carotid artery with intraluminal device, percutaneous approach is a Commodity code that appears in state and local procurement systems but shows no meaningful alignment with recent contract activity. The code nominally describes a specific surgical procedure—left internal carotid artery occlusion performed percutaneously with an intraluminal device—yet recent opportunities posted under this code do not solicit medical devices, implants, or procedure-specific supplies. Instead, the tagged opportunities span independent medical evaluation services, pharmacy benefit management, occupational health surveillance, surgical center-of-excellence networks, temporary health professional staffing, and emergency medical services for juvenile detention. None of these solicitations involve the procurement of carotid artery occlusion devices or related implantable hardware.

The mismatch between the code's clinical scope and the actual work being solicited suggests this code sees little or no authentic state and local procurement activity for its intended commodity. Issuers include county health systems, county benefits consortiums, state transportation departments, and city retirement offices across Florida, California, Washington, Texas, and Arizona, but none are buying the surgical device or procedure described in the code's name. A vendor evaluating pursuit under this code should verify the actual commodity needed before investing in pursuit; the recent opportunities record indicates this code does not reliably map to medical device procurement in state and local markets.